8-KThe WireRoutine
Reg FD Disclosure
Filed Feb 26, 2026 · 4mo ago · Accession 0001193125-26-077105
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Atrium Therapeutics, Inc.
- Ticker
- RNA
- CIK
- 2093101
- Form type
- 8-K
- Filing date
- Feb 26, 2026
- Report date
- Feb 26, 2026
- Document
- d14901d8k.htm
- Size
- 3.1 MB